Retinal Toxicity in Human Immunodeficiency Virus–infected Children Treated With 2′,3′-Dideoxyinosine
- 1 January 1992
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 113 (1) , 1-7
- https://doi.org/10.1016/s0002-9394(14)75744-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Optic neuritis associated with dideoxyinosineThe Lancet, 1991
- Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- ddI — a Good Start, but Still Phase INew England Journal of Medicine, 1990
- In Vivo Activity Against HIV and Favorable Toxicity Profile of 2′,3′-DideoxyinosineScience, 1989
- Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3'-azido-2'3'-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine.The Journal of Experimental Medicine, 1989
- Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.Proceedings of the National Academy of Sciences, 1987
- Strategies for antiviral therapy in AIDSNature, 1987
- Acquired Immunodeficiency Syndrome (AIDS): The Disease and Its Ocular ManifestationsInternational Ophthalmology Clinics, 1986
- Progressive Chorioretinopathy After Receiving ThioridazineArchives of Ophthalmology (1950), 1978
- Thioridazine Pigmentary RetinopathyArchives of Ophthalmology (1950), 1973